The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons

Journal of Neuroscience

Volumn 16, Issue 2, 1996, Pages 436-447

  Nirenberg, Melissa J ^a   Vaughan, Roxanne A ^b   Uhl, George R ^b,c   Kuhar, Michael J ^b,c   Pickel, Virginia M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amphetamine; caudate putamen; cocaine; dendritic release; dopamine reuptake; dopamine transporter; immunogold; neurotoxicity; Parkinson's disease; reverse transport; striatum; substantia nigra

Indexed keywords

CHLORIDE; DOPAMINE; NEUROTOXIN; SODIUM; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CORPUS STRIATUM; DENDRITE; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; ELECTRON MICROSCOPY; IMMUNOCYTOCHEMISTRY; IMMUNOGOLD STAINING; MALE; NERVE ENDING; NERVE FIBER; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SMOOTH ENDOPLASMIC RETICULUM; SUBSTANTIA NIGRA;

EID: 0030031457     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-02-00436.1996     Document Type: Article

References (56)

1. Bannon MJ, Granneman JG, Kapatos G (1995) The dopamine transporter: potential involvement in neuropsychiatric disorders. In: Psychopharmacology: the fourth generation of progress (Bloom FE, Kupfer DJ, eds), pp 179-188. New York: Raven.
2. Beaudet A, Descarries L (1978) The monoamine innervation of rat cerebral cortex: synaptic and non-synaptic axon terminals. Neuroscience 3:851-860.
3. Ben-Shachar D, Zuk R, Glinka Y (1995) Dopamine neurotoxicity: inhibition of mitochondrial respiration. J Neurochem 64:718-723.
4. Bernardini GL, Gu X, Viscardi E, German DC (1991) Amphetamine-induced and spontaneous release of dopamine from A9 and A10 dendrites: an in vitro electrophysiological study in the mouse. J Neural Transm Gen Sect 84:183-193.
5. Björklund A, Lindvall O (1984) Dopamine-containing systems in the central nervous system. In: Handbook of chemical neuroanatomy. Vol II. Classical transmitters in the central nervous system (Björklund A, Hokfelt T, eds). pp 55-121. Amsterdam: Elsevier Science.
6. Bradbury NA, Bridges RJ (1994) Role of membrane trafficking in plasma membrane solute transport. Am J Physiol 267:C1-C24.
7. Cerruti C, Walther DM, Kuhar MJ, Uhl GR (1993) Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Mol Brain Res 18:181-186.
8. Chan J, Aoki C, Pickel VM (1990) Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 33:113-127.
9. Cheramy A, Leviel V, Glowinski J (1981) Dendritic release of dopamine in the substantia nigra. Nature 289:537-542.
10. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI (1995) The dopamine transporter: immunocytochemical characterization and localization in brain. J Neurosci 15:1714-1723.
11. 125I]RTI-55 to dopamine transporters: pharmacology and regional distribution with autoradiography. Synapse 12:37-46.
12. Descarries L, Bosler O, Berthelet F, Des Rosiers MH (1980) Dopaminergic nerve endings visualised by high-resolution autoradiography in adult rat neostriatum. Nature 284:620-622.
13. Edwards RH (1993) Neuronal degeneration and the transport of neurotransmitters. Ann Neurol 34:638-645.
14. Eshleman AJ, Henningsen RA, Neve KA, Janowsky A (1994) Release of dopamine via the human transporter. Mol Pharmacol 45:312-316.
15. Freed C, Revay R, Vaughan RA, Kriek E, Grant S, Uhl GR, Kuhar MJ (1995) Dopamine transporter irnmunoreactivity in rat brain. J Comp Neurol 359:340-349.
16. Geffen LB, Jessell TM, Cuello AC, Iverson LL (1976a) Release of dopamine from dendrites in rat substantia nigra. Nature 260:258-260.
17. Geffen LB, Jessell TM, Cuello AC, Iverson LL (1976b) Nigral and striatal dopamine release under sensory stimuli. Nature 269:340-342.
18. Gerfen CR, Herkenham M, Thibault J (1987) The neostriatal mosaic. II. Patch- and matrix-directed mesostriatal dopaminergic and nondopaminergic systems. J Neurosci 7:3915-3934.
19. Giros B, El Mestikawy S, Bertrand L, Caron G (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295:149-154.
20. Graybiel AM, Moratalla R (1989) Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc Natl Acad Sci USA 86:9020-9024.
21. Griffiths G, Simons K (1986) The trans-Golgi network: sorting at the exit site of the Golgi complex. Science 234:438-443.
22. Hsu SM, Raine L, Fanger H (1981) The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (peroxidase) procedures. J Histochem Cytochem 29:577-599.
23. 3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid, and D-amphetamine. J Pharmacol Exp Ther 262:356-364.
24. Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82:2173-2177.
25. Kaakkola S, Teravainen H (1990) Animal models of parkinsonism. Pharmacol Toxicol 67:95-100.
26. Kilty JE, Lorang D, Amara SG (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254:578-579.
27. Kitayama S, Shimada S, Uhl GR (1992) Parkinsonism-inducing neurotoxin MPPT: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA. Ann Neurol 32:109-111.
28. Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
29. 2+-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J Pharmacol Exp Ther 256:1132-1138.
30. Maley BE, Engle MG, Humphries S, Vascik DA, Howes KA, Newton BW, Elde RP (1990) Monoamine synaptic structure and localization in the central nervous system. J Electron Microsc Tech 15:20-33.
31. 3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies. Brain Res 491:307-315.
32. Mercer L, del Fiacco M, Cuello AC (1979) The smooth endoplasmic reticulum as a possible storage site for dendritic dopamine in substantia nigra neurones. Experientia 35:101-103.
33. Nicholson C Rice ME (1991) Diffusion of ions and transmitters in the brain cell microenvironment. In: Volume transmission in the brain: novel mechanisms for neural transmission (Fuxe K, Agnati LF, eds), pp 279-294. New York: Raven.
34. Nirenberg MJ, Liu Y, Peter D, Edwards RH, Pickel VM (1995) The vesicular monoamine transporter-2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei. Proc Natl Acad Sci USA 92:8773-8777.
35. Nissbrandt H, Sundstrom E, Jonsson G, Hjorth S, Carlsson A (1989) Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacta, pars reticulata, and striatum. J Neurochem 52:1170-1182.
36. Parton RG, Simons K, Dotti CG (1992) Axonal and dendritic endocytic pathways in cultured neurons. J Cell Biol 119:123-137.
37. Peters A, Palay SL, Webster HD (1991) The fine structure of the nervous system. New York: Oxford UP.
38. Pickel VM (1986) Ultrastructure of central catecholaminergic neurons. In: Neurohistochemistry: modern methods and applications (Panula P, Paivarinta H, Soinila S, eds), pp 397-423. New York: Liss.
39. Pickel VM, Johnson E, Carson M, Chan J (1992) Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine. Brain Res 70:75-86.
40. Pickel VM, Sesack SR (1995) Electron microscopy of central dopamine systems. In: Psychopharmacology: the fourth generation of progress (Bloom FE, Kupfer DJ, eds), pp 257-268. New York: Raven.
41. Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA (1995) Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol Pharmacol 47:368-373.
42. Pifl C, Giros B, Caron MG (1993) Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J Neurosci 13:4246-4253.
43. Quatacker JR, Annaert WG, Miserez BJ, De Potter WP (1992) Immunocytochemical demonstration of dopamine-β-hydroxylase and cytochrome B561 on the axonal reticulum in bovine sympathetic neurons. J Histochem Cytochem 40:1599-1604.
44. Ratieri M, Cerrito F, Cervoni AM, Levi G (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther 208:195-202.
45. Revay R, Vaughan R, Grant S, Kuhar MJ (1996) Dopamine transporter immunohistochemistry in median eminence, amygdala and other areas. Synapse, in press.
46. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223.
47. Robertson GS, Damsma G, Fibiger HC (1991) Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J Neurosci 11:2209-2216.
48. Rosales MG, Flores G, Hernández S, Martínez-Fong D, Aceves J (1994) Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat. Brain Res 645:335-337.
49. Roth RH, Elsworth JD (1995) Biochemical pharmacology of midbrain dopamine neurons. In: Psychopharmacology: the fourth generation of progress (Bloom FE, Kupfer DJ, eds), pp 227-243. New York: Raven.
50. Seeman P (1995) Dopamine receptors: clinical correlates. In: Psychopharmacology: the fourth generation of progress (Bloom FE, Kupfer DJ, eds). pp 295-302. New York: Raven.
51. Shimada S, Kitayama S, Lin CL, Patel A, Nanthakumar E, Gregor P, Kuhar M, Uhl G (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA [published erratum appears in Science (1992) 255:1195]. Science 254:576-578.
52. Shimada S, Kitayama S, Walther D, Uhl G (1992) Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Mol Brain Res 13:359-362.
53. Sitges M, Reyes A, Chiu LM (1994) Dopamine transporter mediated release of dopamine: role of chloride. J Neurosci Res 39:11-22.
54. Sulzer D, Maidment NT, Rayport S (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60:527-535.
55. +) in mice. Eur J Pharmacol 131:289-292.
56. Tuffet S, Grandier-Vazeilles X, Geffard M (1987) Monoclonal antibodies against glutaraldehyde-conjugated dopamine. J Neurochem 49:487-494.